HomeNewsBusinessEconomyFarmers' agitation less about content of farm laws, more about lack of trust: Economist Abhijit Banerjee

Farmers' agitation less about content of farm laws, more about lack of trust: Economist Abhijit Banerjee

On the issue of loan moratorium, Abhijit Banerjee said that country's policymakers, the Reserve Bank of India (RBI) in particular, had worked towards ensuring that the banks don’t collapse.

December 10, 2020 / 23:32 IST
Story continues below Advertisement
Nobel laureate and renowned economist Abhijit Banerjee.
Nobel laureate and renowned economist Abhijit Banerjee.

Economist Abhijit Banerjee, who won the 2019 Nobel Prize for Economics, on December 10 said that the ongoing farmers' protest is less to do with the content of the contentious farm laws and more about lack of trust, ostensibly between the farmers and the government.

"This (the farm legislations) is a move at a time when states are feeling economically threatened because the economy is not delivering as much as it was earlier," Banerjee said.

Story continues below Advertisement

Speaking about the Indian economy, Banerjee said that India is going to end the year 10 percent short from where the country was, considering the massive demand shock and low investment.

"After a 24% reduction (in June quarter), you might have imagined that you would get a 15% bounce up. We are going to end the year with 10% short of where we were. There are reasons why it would be sticky and one of them is there is a massive demand shock. Investment is very slow. People are scared and they are sitting on whatever cash they have," LiveMint quote Banerjee saying at HTLS 2020.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show